Subcutaneous implant-based contraception. A four-year experience and impact on quality of life improvement in socially excluded women
Section: Originales
Authors
1M. José Espinaco Garrido, 1José Román Oliver, 2Juan Muñoz Jigato, 3Cristina Domínguez Espinaco
Position
1Matrona de Atención Primaria. Distrito Sevilla. 2Estudiante de Enfermería.3Enfermera.
Contact email: pepaespinaco@hotmail.com
Abstract
Purpose: The problem of shanty slums in Seville has a special significance, probably due to the fact that Seville has the oldest and one of the largest slums in Europe, the so-called “Vacie”. Some 800 socially excluded people are currently living there. Women have there the added problem of a common early-age reproduction and a high number of unintended pregnancies. Our main objective was to review a four-year experience with contraceptive subcutaneous implantation in this population. Secondary aims were to understand socio-obstetric profile of women, reasons for using or withdrawing such contraceptive devices, and implant acceptability and tolerability.
Material and methods: A retrospective observational study in a sample of 269 contraceptive implants in women aged 15 to 44 years, over the period 2010 – 2013 was carried out. Relevant data were obtained during review exams and were recorded in a specifically developed registry of implantation/withdrawal.
Results: Mean age of participants was 27.03 years. Mean abortion rate was 0.68% and mean use of urgent contraception was 0.51%. Reported reasons for using such a contraceptive method were as follows: 34.20% due to difficulties for using alternative methods; 13.40% because of intolerance; and 52.40% due to low economic resources. Reasons for withdrawal were as follows: device withdrawal was decided by 3.65% of users before completing three years of use. Intolerance to bleeding patterns was the alleged reason in 62% of them and intended pregnancy was the reason in 34.20 %. Contraceptive method use continuity was 96.35%, with 97.50% tolerability. All women in the study reported this was an effective method and 84.32% considered it to be excellent.
Conclusions: An excellent result, similar to the one in other studies, was achieved. A repeated implantation was performed in 90% of users after first implant withdrawal due to expiration.
Keywords:
Subcutaneous hormonal implant; socially excluded population; implant acceptability and tolerability
Versión en Español
Título:
Artículo completo no disponible en este idioma / Full article is not available in this language
Bibliography
- Información demográfica de la población de El Vacie y sus características. Protocolo del Distrito Sanitario Sevilla 2007/09; 98:357.
- Organización de Naciones Unidas (ONU). 4ª Conferencia Mundial sobre la Mujer. Declaración y Plataforma de Acción de Beijing. Beijing; 1995.
- Organización Mundial de la Salud (OMS). Recomendaciones sobre prácticas seleccionadas para el uso de anticonceptivos. 2ª ed. Ginebra: OMS; 2005.
- Bhatia P, Nangia S, Aggarwal S, Tewari C. Implanon: Subdermal Single Rod Contraceptive Implant India. Aug 2011; 61(4):422-425.
- Trillo C, Navarro JA, Luque MA, Seoane J. Guía Práctica de Planificación Familiar en Atención Primaria. 2ª ed. Samfyc; 2008.
- Aisien AO, Enosolease ME. Safety, efficacy and acceptability of implanon a single rod implantable contraceptive (etonogestrel) in University of Benin Teaching Hospital. Niger J Clin Pract 2010 Sep; 13(3):331-335.
- Heather Hohmann. Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive. Patient Prefer Adherence 2009; 3: 205-211.
- Madden T, Eisenberg DL, Zhao Q, Buckel C, Secura GM, Peipert JF. Continuation of the etonogestrel implant in women undergoing immediate postabortion placement. Obstet Gynecol 2012 Nov; 120(5):1053-59.
- Arribas Mir L, Rueda Lozano D, Agrela Cardona M, Cedeño Benavides T, Olvera Porcel C, Bueno Cavanillas A. Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain. Contraception 2009 Nov; 80(5):457-462.
- Power J, Franch R, Cowan F. Anticonceptivos implantables subdérmicos versus otras formas de anticonceptivos reversibles como métodos eficaces de prevención de embarazo. La Biblioteca Cochrane Plus 2008 número 4.
- Mattos I. Satisfacción, eficacia y efectos secundarios del implante subdérmico (Implanon®) en dos centros de atención a la mujer de la Comunidad de Madrid. Contracepción enero-febrero 2004; 21(1):93-99.
- Domínguez V, Ávila P, Espinaco MJ, Román J. Estudio sobre accesibilidad y tolerabilidad del uso de implantes hormonales subdérmicos en una población de exclusión social en Sevilla. Aten Primaria 2011; 43(12):656-661.